Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Implementation Science : IS|May 29, 2016
Cluster randomised trial of a tailored intervention to improve the management of overweight and obesity in primary care in EnglandJane Goodfellow, Shona Agarwal, Fawn Harrad, et al.
Trials|November 23, 2015
A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility studyDavid J Bowrey, Melanie Baker, Vanessa Halliday, et al.
Cardiovascular Diabetology|April 27, 2013
The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) studyArne Ring, Tobias Brand, Sreeraj Macha, et al.
Clinical Pharmacokinetics|November 9, 2010
Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjectsSilke Retlich, Vincent Duval, Arne Ring, et al.
British Journal of Clinical Pharmacology|October 26, 2016
A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 studyArne Ring, Tom Morris, Marcin Wozniak, et al.
Deutsche Medizinische Wochenschrift (1946)|February 25, 2017
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study]David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 19, 2012
Linagliptin increases incretin levels, lowers glucagon, and improves glycemic control in type 2 diabetes mellitusThomas Rauch, Ulrike Graefe-Mody, Carolyn F Deacon, et al.
British Journal of Clinical Pharmacology|September 14, 2021
Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approachStephan Schaller, Frederico S Martins, Pavel Balazki, et al.
American Heart Journal|November 26, 2013
Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular diseaseJennifer B Green, M Angelyn Bethel, Sanjoy K Paul, et al.
Diabetes Care|January 17, 2013
Evaluation of a self-administered oral glucose tolerance testM Angelyn Bethel, Hermione C Price, Harald Sourij, et al.
Pageof 4